|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
12
|
|
pubmed:dateCreated |
2000-3-1
|
|
pubmed:abstractText |
Prolonged anticoagulation aiming at International Normalized Ratio (INR) values > 3.0 has been recommended for patients with thrombosis and the antiphospholipid-antibody syndrome. We evaluated the influence of anticoagulant antibodies in two different prothrombin time (PT) assays carried out on plasma from lupus anticoagulant patients on oral anticoagulation.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Dec
|
|
pubmed:issn |
0390-6078
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
84
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1065-74
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:10586206-Adult,
pubmed-meshheading:10586206-Aged,
pubmed-meshheading:10586206-Antibodies, Antiphospholipid,
pubmed-meshheading:10586206-Anticoagulants,
pubmed-meshheading:10586206-Antiphospholipid Syndrome,
pubmed-meshheading:10586206-Female,
pubmed-meshheading:10586206-Humans,
pubmed-meshheading:10586206-International Normalized Ratio,
pubmed-meshheading:10586206-Lupus Coagulation Inhibitor,
pubmed-meshheading:10586206-Male,
pubmed-meshheading:10586206-Middle Aged,
pubmed-meshheading:10586206-Prothrombin Time,
pubmed-meshheading:10586206-Thrombosis
|
|
pubmed:year |
1999
|
|
pubmed:articleTitle |
Interference of lupus anticoagulants in prothrombin time assays: implications for selection of adequate methods to optimize the management of thrombosis in the antiphospholipid-antibody syndrome.
|
|
pubmed:affiliation |
Coagulation Service and Thrombosis Research Unit, Scientific Institute H S. Raffaele, Milan, Italy.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
